- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Riboflavin Transporters RFVT/SLC52A Mediate Translocation of Riboflavin, Rather than FMN or FAD, across Plasma Membrane
-
- Jin Congyun
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
-
- Yao Yoshiaki
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
-
- Yonezawa Atsushi
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
-
- Imai Satoshi
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
-
- Yoshimatsu Hiroki
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
-
- Otani Yuki
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
-
- Omura Tomohiro
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
-
- Nakagawa Shunsaku
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
-
- Nakagawa Takayuki
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
-
- Matsubara Kazuo
- Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital
Search this article
Description
<p>Riboflavin (vitamin B2) plays a role in various biochemical oxidation-reduction reactions. Flavin mononucleotide (FMN) and FAD, the biologically active forms, are made from riboflavin. Riboflavin transporters (RFVTs), RFVT1-3/Slc52a1-3, have been identified. However, the roles of human (h)RFVTs in FMN and FAD homeostasis have not yet been fully clarified. In this study, we assessed the contribution of each hRFVT to riboflavin, FMN and FAD uptake and efflux using in vitro studies. The transfection of hRFVTs increased cellular riboflavin concentrations. The uptake of riboflavin by human embryonic kidney cells transfected with hRFVTs was significantly increased, and the efflux was accelerated in a time-dependent manner. However, the uptake and efflux of FMN and FAD hardly changed. These results strongly suggest that riboflavin, rather than FMN or FAD, passes through plasma membranes via hRFVTs. Our findings could suggest that hRFVTs are involved in riboflavin homeostasis in the cells, and that FMN and FAD concentrations are regulated by riboflavin kinase and FAD synthase.</p>
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 40 (11), 1990-1995, 2017
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679610687744
-
- NII Article ID
- 130006191824
-
- NII Book ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- HANDLE
- 2433/276093
-
- NDL BIB ID
- 028602406
-
- PubMed
- 29093349
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- IRDB
- NDL Search
- Crossref
- PubMed
- CiNii Articles
- KAKEN
- OpenAIRE
-
- Abstract License Flag
- Disallowed